UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 96

Sortiert nach

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

Clinical infectious diseases, 2009-06, Vol.48 (12), p.1695-1703

2009

Volltextzugriff (PDF)

Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis

Medical mycology (Oxford), 2016-01, Vol.54 (1), p.1-22

2016

Volltextzugriff (PDF)

Has Antifungal Susceptibility Testing Come of Age?

Clinical infectious diseases, 2002-10, Vol.35 (8), p.982-989

2002

Volltextzugriff (PDF)

Risk Factors for Candidal Bloodstream Infections in Surgical Intensive Care Unit Patients: The NEMIS Prospective Multicenter Study

Clinical infectious diseases, 2001-07, Vol.33 (2), p.177-186

2001

Volltextzugriff (PDF)

Nosocomial Bloodstream Infections in United States Hospitals: A Three-Year Analysis

Clinical infectious diseases, 1999-08, Vol.29 (2), p.239-244

1999

Volltextzugriff (PDF)

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15)

Journal of antimicrobial chemotherapy, 2017-05, Vol.72 (5), p.1386-1395

2017

Volltextzugriff (PDF)

Antimicrobial Resistance Trends and Outbreak Frequency in United States Hospitals

Clinical infectious diseases, 2004-01, Vol.38 (1), p.78-85

2004

Volltextzugriff (PDF)

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

Clinical infectious diseases, 2013-06, Vol.56 (12), p.1724-1732

2013

Volltextzugriff (PDF)

Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates

Journal of antimicrobial chemotherapy, 2016-10, Vol.71 (10), p.2868-2873

2016

Volltextzugriff (PDF)

In Candida albicans, White-Opaque Switchers Are Homozygous for Mating Type

Genetics (Austin), 2002-10, Vol.162 (2), p.737-745

2002

Volltextzugriff (PDF)

Nosocomial Bloodstream Infections Caused by Acinetobacter Species in United States Hospitals: Clinical Features, Molecular Epidemiology, and Antimicrobial Susceptibility

Clinical infectious diseases, 2000-09, Vol.31 (3), p.690-697

2000

Volltextzugriff (PDF)

Overview of the Epidemiological Profile and Laboratory Detection of Extended-Spectrum β-Lactamases

Clinical infectious diseases, 2006-04, Vol.42, p.S153-S163

2006

Volltextzugriff (PDF)

Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16

Journal of antimicrobial chemotherapy, 2018-10, Vol.73 (10), p.2748-2756

2018

Volltextzugriff (PDF)

Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections

Medical mycology (Oxford), 2022-05, Vol.60 (5)

2022

Volltextzugriff (PDF)

Rapid Detection of Antibiotic-Resistant Organism Carriage for Infection Prevention

Clinical infectious diseases, 2013-06, Vol.56 (11), p.1614-1620

2013

Volltextzugriff (PDF)

Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centres

Journal of antimicrobial chemotherapy, 2019-05, Vol.74 (5), p.1306-1310

2019

Volltextzugriff (PDF)

Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST)

Journal of antimicrobial chemotherapy, 2013-04, Vol.68 (4), p.858-863

2013

Volltextzugriff (PDF)

AWARE Ceftaroline Surveillance Program (2008–2010): Trends in Resistance Patterns Among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States

Clinical infectious diseases, 2012-09, Vol.55 (suppl_3), p.S187-S193

2012

Volltextzugriff (PDF)

Contemporary Tools for the Diagnosis and Management of Invasive Mycoses

Clinical infectious diseases, 2006-08, Vol.43 (Supplement-1), p.S15-S27

2006

Volltextzugriff (PDF)

ZAAPS Program results for 2015: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 32 countries

Journal of antimicrobial chemotherapy, 2017-11, Vol.72 (11), p.3093-3099

2017

Volltextzugriff (PDF)

“Gesundheit!” Sneezing, Common Colds, Allergies, and Staphylococcus aureus Dispersion

The Journal of infectious diseases, 2006-10, Vol.194 (8), p.1119-1126

2006

Volltextzugriff (PDF)

Antimicrobial activity of oritavancin and comparator agents when tested against Gram-positive bacterial isolates causing infections in cancer patients (2014-16)

Journal of antimicrobial chemotherapy, 2018-04, Vol.73 (4), p.916-922

2018

Volltextzugriff (PDF)

Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America : report from the second year of the SENTRY Antimicrobial Surveillance Program (1998)

Journal of antimicrobial chemotherapy, 2000-03, Vol.45 (3), p.295-303

2000

Volltextzugriff (PDF)

Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods

Journal of antimicrobial chemotherapy, 2011-11, Vol.66 (11), p.2581-2584

2011

Volltextzugriff (PDF)

Outbreak of Severe Pseudomonas aeruginosa Infections Caused by a Contaminated Drain in a Whirlpool Bathtub

Clinical infectious diseases, 2000-12, Vol.31 (6), p.1331-1337

2000

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Aktive Filter

KollektioneBooks on EBSCOhost

KollektionOxford University Press Journals Current

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(96)

Sprache

Englisch
(96)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(74)
Science & Technology
(74)
Infectious Diseases
(72)
Microbiology
(66)
Humans
(55)
Biological And Medical Sciences
(51)
Immunology
(48)
Medical Sciences
(48)
Infections
(43)
Microbial Sensitivity Tests
(28)
Fungal Infections
(21)
Epidemiology
(20)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(19)
Male
(19)
Pharmacology. Drug Treatments
(19)
Antifungals
(17)
Female
(17)
Adult
(16)
Antimicrobials
(16)
Blood
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis

Has Antifungal Susceptibility Testing Come of Age?

Risk Factors for Candidal Bloodstream Infections in Surgical Intensive Care Unit Patients: The NEMIS Prospective Multicenter Study

Nosocomial Bloodstream Infections in United States Hospitals: A Three-Year Analysis

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15)

Antimicrobial Resistance Trends and Outbreak Frequency in United States Hospitals

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates

In Candida albicans, White-Opaque Switchers Are Homozygous for Mating Type

Nosocomial Bloodstream Infections Caused by Acinetobacter Species in United States Hospitals: Clinical Features, Molecular Epidemiology, and Antimicrobial Susceptibility

Overview of the Epidemiological Profile and Laboratory Detection of Extended-Spectrum β-Lactamases

Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16

Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections

Rapid Detection of Antibiotic-Resistant Organism Carriage for Infection Prevention

Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centres

Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST)

AWARE Ceftaroline Surveillance Program (2008–2010): Trends in Resistance Patterns Among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States

Contemporary Tools for the Diagnosis and Management of Invasive Mycoses

ZAAPS Program results for 2015: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 32 countries

“Gesundheit!” Sneezing, Common Colds, Allergies, and Staphylococcus aureus Dispersion

Antimicrobial activity of oritavancin and comparator agents when tested against Gram-positive bacterial isolates causing infections in cancer patients (2014-16)

Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America : report from the second year of the SENTRY Antimicrobial Surveillance Program (1998)

Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods

Outbreak of Severe Pseudomonas aeruginosa Infections Caused by a Contaminated Drain in a Whirlpool Bathtub

Aktive Filter

Suchergebnisse filtern